Omnicell Inc (OMCL) 26.79 $OMCL
Omnicell Announces Second Quarter Results
PR Newswire - Thu Jul 31, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its second quarter ended June 30, 2014.
Atlantic Health Selects Omnicell Unity Enterprise Platform to Upgrade Existing Medication Automation Solutions
PR Newswire - Tue Jul 29, 7:00AM CDT
Omnicell Inc., (NASDAQ:OMCL), today announced that Atlantic Health System has selected Omnicell to be its new provider of automated medication management solutions and data analytics tools in three acute care medical centers -Morristown Medical Center, Overlook Medical Center and Newton Medical Center. For the first time, Atlantic Health pharmacists and nurses will have access to standardized automated medication systems designed to improve workflow, increase patient safety and help enable nurses to spend more time with patients.
Omnicell to Release Second Quarter 2014 Earnings Results on July 31
PR Newswire - Thu Jul 24, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, July 31, to discuss the Company's Second Quarter 2014 financial results.
Omnicell Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 2:30PM CDT
On Jun 17, 2014, Zacks Investment Research upgraded Onmicell, Inc. (OMCL) to a Zacks Rank #5 (Strong Sell).
2018 Medical Automation Industry Forecasts in North America, Europe, Asia & ROW Analysis Now at ReportsnReports.com
PRWeb - Sun Jun 08, 11:30AM CDT
North America is the largest market for medical automation, followed by Europe and Asia. However, the Asian and RoW markets are expected to witness a healthy growth over the next five years.
Omnicell Retains Balanced View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 29, 1:50PM CDT
On May 29, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
Allina Health Selects Omnicell for Medication Automation Solutions
PR Newswire - Wed May 28, 10:45AM CDT
Omnicell Inc., (NASDAQ:OMCL), today announced that Allina Health has selected the company to be its provider of automated medication solutions for the 12 acute care hospitals across its integrated delivery network. Allina Health is known for offering advanced technology and high quality of care to patients in communities throughout Minnesota and western Wisconsin. With Omnicell, its pharmacists and nurses will have access to solutions designed to improve workflow and enable staff to spend more time engaging patients.
Omnicell Achieves International ISO Environmental Certification
PR Newswire - Tue Apr 01, 7:00AM CDT
Today Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare providers, announced it achieved certification for International Organization for Standardization (ISO) 14001:2004 Environmental Management System (EMS), demonstrating the company's commitment to lowering its environmental impact. The EMS is a framework that helps a company achieve its environmental goals through consistent control of its operations.
Cerner to Offer OTTR Solutions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 6:00PM CDT
Currently, OTTR is the leading patient tracking application and patient record system specifically tailored for solid organ transplant centers and CERN will be the only electronic health record provider to offer it
15.1% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Fri Mar 28, 4:58PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 15.07% as of today's recent price of $27.71.
Patients Report Use of MTS Blister Card Improves Confidence in Safely Taking Medications and Reducing Emergency Room Visits
PR Newswire - Fri Mar 28, 7:18AM CDT
MTS, an Omnicell® Company and leading international provider of adherence packaging systems, today applauds the patient medication adherence research to be presented by Sharrel Pinto, BSPharm, DMM, MS, PhD, of the University of Toledo College of Pharmacy and Pharmaceutical Sciences at the American Pharmacists Association (APhA) 2014 Conference in Orlando. The research is the first to evaluate patient confidence in self administration of their medications between MTS RxMap®, an adherence blister card filled and sealed by the pharmacy, and self-organized pill vials, pillboxes, and medication pouches. The results showed that patients' confidence in taking their medications increased from 7% to 93% when using RxMap blister cards. Additionally, 36% of patients credited the blister card for playing a role in improving clinical results and helping reduce ER visits and hospitalizations.
Updated Research Report on Merge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 9:30AM CDT
On Mar 24, 2014, we issued an updated research report on Merge Healthcare.
Omnicell Has Returned 23.8% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Mar 21, 11:07AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 23.84% as of today's recent price of $29.82.
Uptrend Call Working As Omnicell Stock Rises 20.5% (OMCL)
Comtex SmarTrend(R) - Fri Mar 14, 9:44AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 20.53% as of today's recent price of $29.02.
Why Omnicell (OMCL) Could Be an Impressive Growth Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:40AM CDT
Omnicell is well-positioned for future earnings growth and could be a strong growth stock contender
Shares of OMCL Up 19.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 07, 9:19AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 19.68% as of today's recent price of $28.82.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
Vaica Announces SimpleMed+, its Next Generation Medication Adherence Management Solution for Chronically-ill and Hospital Discharged Patients
PR Newswire - Tue Feb 25, 9:21AM CST
Vaica today announced the commercial availability of SimpleMed+, the latest addition to its medication adherence and telehealth management platform. SimpleMed+ is a medication dispenser for use by patients who take a number of oral medications per day. Medications are loaded into the dispenser by a simple insertion of a standard pharmacy-prefilled multi-med blister packs, ensuring an error-free loading of the dispenser with a weekly supply of medications and alleviating the need for a nurse or a caregiver to assist or supervise the patient's medication intake process. SimpleMed+ currently supports standard multi-med blister packs made by MTS, a subsidiary of Omnicell (NASDAQ: OMCL), with support for other brands of multi-med blister packs to follow soon. SimpleMed+ is also a telehealth hub that collects and uploads the patient's vital signs data directly into the patient's cloud-based EHR. It has an integrated NFC reader for home-care workforce timesheet management, and a QR code reader for the transfer of blister-specific information. SimpleMed+ connects with Vaica's cloud service via its built-in cellular communications device or via Qualcomm's 2net.
Omnicell To Present At The Cowen And Company 34th Annual Health Care Conference
PR Newswire - Tue Feb 25, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA.
Omnicell Announces Second Quarter Results
PR Newswire - Thu Jul 31, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its second quarter ended June 30, 2014.
Atlantic Health Selects Omnicell Unity Enterprise Platform to Upgrade Existing Medication Automation Solutions
PR Newswire - Tue Jul 29, 7:00AM CDT
Omnicell Inc., (NASDAQ:OMCL), today announced that Atlantic Health System has selected Omnicell to be its new provider of automated medication management solutions and data analytics tools in three acute care medical centers -Morristown Medical Center, Overlook Medical Center and Newton Medical Center. For the first time, Atlantic Health pharmacists and nurses will have access to standardized automated medication systems designed to improve workflow, increase patient safety and help enable nurses to spend more time with patients.
Omnicell to Release Second Quarter 2014 Earnings Results on July 31
PR Newswire - Thu Jul 24, 3:01PM CDT
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, July 31, to discuss the Company's Second Quarter 2014 financial results.
Omnicell Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 2:30PM CDT
On Jun 17, 2014, Zacks Investment Research upgraded Onmicell, Inc. (OMCL) to a Zacks Rank #5 (Strong Sell).
2018 Medical Automation Industry Forecasts in North America, Europe, Asia & ROW Analysis Now at ReportsnReports.com
PRWeb - Sun Jun 08, 11:30AM CDT
North America is the largest market for medical automation, followed by Europe and Asia. However, the Asian and RoW markets are expected to witness a healthy growth over the next five years.
Omnicell Retains Balanced View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 29, 1:50PM CDT
On May 29, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
Allina Health Selects Omnicell for Medication Automation Solutions
PR Newswire - Wed May 28, 10:45AM CDT
Omnicell Inc., (NASDAQ:OMCL), today announced that Allina Health has selected the company to be its provider of automated medication solutions for the 12 acute care hospitals across its integrated delivery network. Allina Health is known for offering advanced technology and high quality of care to patients in communities throughout Minnesota and western Wisconsin. With Omnicell, its pharmacists and nurses will have access to solutions designed to improve workflow and enable staff to spend more time engaging patients.
Omnicell Achieves International ISO Environmental Certification
PR Newswire - Tue Apr 01, 7:00AM CDT
Today Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare providers, announced it achieved certification for International Organization for Standardization (ISO) 14001:2004 Environmental Management System (EMS), demonstrating the company's commitment to lowering its environmental impact. The EMS is a framework that helps a company achieve its environmental goals through consistent control of its operations.
Cerner to Offer OTTR Solutions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 6:00PM CDT
Currently, OTTR is the leading patient tracking application and patient record system specifically tailored for solid organ transplant centers and CERN will be the only electronic health record provider to offer it
15.1% Return Seen to Date on SmarTrend Omnicell Call (OMCL)
Comtex SmarTrend(R) - Fri Mar 28, 4:58PM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 15.07% as of today's recent price of $27.71.
Patients Report Use of MTS Blister Card Improves Confidence in Safely Taking Medications and Reducing Emergency Room Visits
PR Newswire - Fri Mar 28, 7:18AM CDT
MTS, an Omnicell® Company and leading international provider of adherence packaging systems, today applauds the patient medication adherence research to be presented by Sharrel Pinto, BSPharm, DMM, MS, PhD, of the University of Toledo College of Pharmacy and Pharmaceutical Sciences at the American Pharmacists Association (APhA) 2014 Conference in Orlando. The research is the first to evaluate patient confidence in self administration of their medications between MTS RxMap®, an adherence blister card filled and sealed by the pharmacy, and self-organized pill vials, pillboxes, and medication pouches. The results showed that patients' confidence in taking their medications increased from 7% to 93% when using RxMap blister cards. Additionally, 36% of patients credited the blister card for playing a role in improving clinical results and helping reduce ER visits and hospitalizations.
Updated Research Report on Merge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 9:30AM CDT
On Mar 24, 2014, we issued an updated research report on Merge Healthcare.
Omnicell Has Returned 23.8% Since SmarTrend Recommendation (OMCL)
Comtex SmarTrend(R) - Fri Mar 21, 11:07AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 23.84% as of today's recent price of $29.82.
Uptrend Call Working As Omnicell Stock Rises 20.5% (OMCL)
Comtex SmarTrend(R) - Fri Mar 14, 9:44AM CDT
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 20.53% as of today's recent price of $29.02.
Why Omnicell (OMCL) Could Be an Impressive Growth Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:40AM CDT
Omnicell is well-positioned for future earnings growth and could be a strong growth stock contender
Shares of OMCL Up 19.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 07, 9:19AM CST
SmarTrend identified an Uptrend for Omnicell (NASDAQ:OMCL) on November 22nd, 2013 at $24.08. In approximately 4 months, Omnicell has returned 19.68% as of today's recent price of $28.82.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
Vaica Announces SimpleMed+, its Next Generation Medication Adherence Management Solution for Chronically-ill and Hospital Discharged Patients
PR Newswire - Tue Feb 25, 9:21AM CST
Vaica today announced the commercial availability of SimpleMed+, the latest addition to its medication adherence and telehealth management platform. SimpleMed+ is a medication dispenser for use by patients who take a number of oral medications per day. Medications are loaded into the dispenser by a simple insertion of a standard pharmacy-prefilled multi-med blister packs, ensuring an error-free loading of the dispenser with a weekly supply of medications and alleviating the need for a nurse or a caregiver to assist or supervise the patient's medication intake process. SimpleMed+ currently supports standard multi-med blister packs made by MTS, a subsidiary of Omnicell (NASDAQ: OMCL), with support for other brands of multi-med blister packs to follow soon. SimpleMed+ is also a telehealth hub that collects and uploads the patient's vital signs data directly into the patient's cloud-based EHR. It has an integrated NFC reader for home-care workforce timesheet management, and a QR code reader for the transfer of blister-specific information. SimpleMed+ connects with Vaica's cloud service via its built-in cellular communications device or via Qualcomm's 2net.
Omnicell To Present At The Cowen And Company 34th Annual Health Care Conference
PR Newswire - Tue Feb 25, 7:00AM CST
Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA.
